PROTHENA CORP PUBLIC LTD CO·4

Oct 1, 9:18 PM ET

Selkoe Dennis J. 4

4 · PROTHENA CORP PUBLIC LTD CO · Filed Oct 1, 2021

Insider Transaction Report

Form 4
Period: 2021-10-01
Transactions
  • Sale

    Ordinary Shares, par value $0.01 per share

    2021-10-01$66.35/sh1,757$116,5846,088 total
  • Sale

    Ordinary Shares, par value $0.01 per share

    2021-10-01$68.74/sh1,237$85,0373,551 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-10-015,00011,000 total
    Exercise: $9.23From: 2020-05-18Exp: 2029-05-22Ordinary Shares (5,000 underlying)
  • Sale

    Ordinary Shares, par value $0.01 per share

    2021-10-01$69.69/sh706$49,2022,845 total
  • Exercise/Conversion

    Ordinary Shares, par value $0.01 per share

    2021-10-01$9.23/sh+5,000$46,1507,845 total
  • Sale

    Ordinary Shares, par value $0.01 per share

    2021-10-01$67.96/sh1,300$88,3534,788 total
Holdings
  • Ordinary Shares, par value $0.01 per share

    (indirect: By Spouse)
    1,363
Footnotes (5)
  • [F1]The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The transaction was executed in multiple trades in prices ranging from $66.14 to $67.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]The transaction was executed in multiple trades in prices ranging from $67.33 to $68.26, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F4]The transaction was executed in multiple trades in prices ranging from $68.44 to $69.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F5]The transaction was executed in multiple trades in prices ranging from $69.49 to $70.44, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4